Comparison Of The Protective Effects Of Selective Endothelin-A Receptor Antagonist Ambrisentan And Dual Endothelin-A/B Receptor Antagonist Bosentan İn Experimental Renal Ischemia Reperfusion Injury
Program
KU Authors
KU-Authors
Co-Authors
Advisor
Date
Language
English